Efficacy and safety of oral Morphine versus oral Prolonged-Release Oxycodone/Naloxone in opioid-naive cancer patients: a propensity analysis

被引:0
|
作者
Greco, M. T. [1 ]
Roberto, A. [2 ]
Legramandi, L. [2 ]
Galli, F. [2 ]
Corli, O. [2 ]
机构
[1] Univ Milan, Unita Stat Med & Biometria GA Maccacaro, Dipartimento Sci Clin & Comunia, Milan, Italy
[2] IRCCS Ist Ric Farmacol Mario Negri, Dipartimento Oncol, Lab Metodol Ric Clin, Milan, Italy
关键词
D O I
10.1093/annonc/mdw344.1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
R01
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of oral Prolonged-Release Oxycodone/Naloxone in opioid-naive cancer patients: results from GREAT study
    Legramandi, L.
    Rulli, E.
    Stupia, S. F.
    Roberto, A.
    Corli, O.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naive cancer patients: a propensity analysis
    Lazzari, Marzia
    Greco, Maria Teresa
    Marcassa, Claudio
    Finocchi, Simona
    Caldarulo, Clarissa
    Corli, Oscar
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5863 - 5872
  • [3] Prolonged-release oxycodone/naloxone in opioid-naive patients - subgroup analysis of a prospective observational study
    Hesselbarth, Sabine
    Hermanns, Kai
    Oepen, Petra
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 457 - 464
  • [4] Efficacy and tolerability of transdermal fentanyl versus oral prolonged-release oxycodone/naloxone in patients with moderate to severe cancer pain: A propensity analysis comparison
    Roberto, A.
    Greco, M. T.
    Legramandi, L.
    Galli, F.
    Corli, O.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Combined oral prolonged-release oxycodone and naloxone in chronic pain management
    Mercadante, Sebastiano
    Giarratano, Antonello
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (01) : 161 - 166
  • [6] Oral Prolonged-Release Oxycodone-Naloxone: Analgesic Response, Safety Profile, and Factors Influencing the Response in Patients With Advanced Cancer
    Corli, Oscar
    Iorno, Vittorio
    Legramandi, Lorenzo
    Rulli, Eliana
    Roberto, Anna
    Azzarello, Giuseppe
    Schiavon, Stefania
    Cavanna, Luigi
    De Santis, Stefano
    Cartoni, Claudio
    Di Marco, Pierangelo
    Dauri, Mario
    Mistretta, Rosario
    Bortolussi, Roberto
    Clerico, Mario
    Pacchioni, Manuela
    Crispino, Carlo
    Marabese, Mirko
    Corsi, Nicole
    Natoli, Silvia
    Lipari, Gaspare
    di Sole, Hospice Raggio
    Luzi, Marta
    Palumbo, Giovanna
    Trentin, Leonardo
    PAIN PRACTICE, 2019, 19 (06) : 633 - 643
  • [7] Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain
    Clemens, Katri Elina
    Mikus, Gerd
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) : 297 - 310
  • [8] Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence
    Morlion, Bart J.
    Mueller-Lissner, Stefan A.
    Vellucci, Renato
    Leppert, Wojciech
    Coffin, Benoit C.
    Dickerson, Sara L.
    O'Brien, Tony
    PAIN PRACTICE, 2018, 18 (05) : 647 - 665
  • [9] Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
    Guerriero, Fabio
    Sgarlata, Carmelo
    Marcassa, Claudio
    Ricevuti, Giovanni
    Rollone, Marco
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 1 - 11
  • [10] A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis
    Roberto, A.
    Greco, M. T.
    Legramandi, L.
    Galli, F.
    Galli, M.
    Corli, O.
    JOURNAL OF PAIN RESEARCH, 2017, 10 : 2123 - 2133